Insider Transactions Reported by 10 Insiders of ENDRA Life Sciences Inc.

Symbol: NDRA on Nasdaq
Location: Ann Arbor, MI

Quick Takeaways

NDRA - ENDRA Life Sciences Inc. has 10 insiders with reported activity on this page.
No net insider buy/sell flow is currently reported for the last year.
Recent transaction rows are available for direct filing-level review.

What Changed

No meaningful buy/sell imbalance is currently visible in the one-year window.
Activity will update as new Forms 3/4/5 are filed.

Why This Matters

This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.

Source Evidence

Filed on Form 4

Issuer insider activity is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Insider trading overview

Last 12 months

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 17 Apr 2025.

Buys

Shares: 0

Insiders: 0

Sells

Shares: 0

Insiders: 0

Net

Shares: 0

Insiders: 0

Window (months)	Buy $	Sell $	Net $
0-3	$0	$0	$0
3-6	$0	$0	$0
6-9	$0	$0	$0
9-12	$0	$0	$0

ENDRA Life Sciences Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Valuation	Report Date
Anthony DiGiandomenico	Director	$1,691,146	Mixed	21 Jan 2026
Alexander Y. Tokman	Chief Executive Officer, Director	$359,798	Mixed	02 Mar 2026
Michael Harsh	Director	$332,492	Mixed	21 Jan 2026
Lou Basenese	Director	$332,487	Mixed	21 Jan 2026
Richard Jacroux	Chief Financial Officer	$118,117	Mixed	02 Mar 2026
Michael Milos Thornton	Chief Technology Officer	$56,329	Filing P/S	18 May 2023
Renaud Bertrand Maloberti	Chief Commercial Officer		Mixed	28 Mar 2022
UBS Group AG	Market maker/broker-dealer		Mixed	27 Aug 2024
Francois Roger Michelon	Chief Executive Officer, Director		Mixed	30 Jan 2023
Irina Pestrikova	Senior Director, Finance		Mixed	30 Jan 2023

Top shareholders of ENDRA Life Sciences Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Anthony DiGiandomenico	3/4/5 13D/G	Director	10% from 13D/G	278,233 mixed-class rows	$1,691,146	—	21 Jan 2026	3/4/5 13D/G
Alexander Y. Tokman	3/4/5	Chief Executive Officer, Director	— class O/S missing	101,926	$359,798	—	02 Mar 2026	3/4/5
Michael Harsh	3/4/5	Director	— class O/S missing	65,710	$332,492	—	21 Jan 2026	3/4/5
Lou Basenese	3/4/5	Director	— class O/S missing	65,709	$332,487	—	21 Jan 2026	3/4/5
Altium Capital Management LLC	13F	Company	— class O/S missing	51,900	$235,107	—	31 Dec 2025	13F
Richard Jacroux	3/4/5	Chief Financial Officer	— class O/S missing	33,461	$118,117	—	02 Mar 2026	3/4/5
VANGUARD GROUP INC	13F	Company	— class O/S missing	12,937	$58,604	—	31 Dec 2025	13F
Michael Milos Thornton	3/4/5	Chief Technology Officer	— class O/S missing	34,139	$56,329	—	18 May 2023	3/4/5
MORGAN STANLEY	13F	Company	— class O/S missing	6,946	$31,465	—	31 Dec 2025	13F
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO	13F	Company	— class O/S missing	19	$86	—	31 Dec 2025	13F
UBS Group AG	13F 3/4/5	Company · Market maker/broker-dealer	— class O/S missing	12	$54	—	31 Dec 2025	13F 3/4/5
BANK OF AMERICA CORP /DE/	13F	Company	— class O/S missing	10	$45	—	31 Dec 2025	13F
CITIGROUP INC	13F	Company	— class O/S missing	1	$5	—	31 Dec 2025	13F
Renaud Bertrand Maloberti	3/4/5	Chief Commercial Officer	— class O/S missing	186,430	—	—	28 Mar 2022	3/4/5
ATW Partners Opportunities Management, LLC	13D/G	ATW Master Fund V LP	9.9%	116,024	—	$0	16 Oct 2025	13D/G
John C. Lipman	13D/G	John Carter Lipman	10%	115,477	—	$0	23 Oct 2025	13D/G
Francois Roger Michelon	3/4/5	Chief Executive Officer, Director	— class O/S missing	69,531	—	—	30 Jan 2023	3/4/5
L1 Capital Global Opportunities Master Fund, Ltd.	13D/G	—	3%	35,589	—	$0	14 Nov 2025	13D/G
S.H.N. Financial Investments Ltd.	13D/G	—	3%	35,588	—	$0	14 Nov 2025	13D/G
Irina Pestrikova	3/4/5	Senior Director, Finance	— class O/S missing	8,000	—	—	30 Jan 2023	3/4/5

Recent Insider Transactions by Companies or Individuals for ENDRA Life Sciences Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider	Symbol	Class	Transaction	%	Shares	Shares Owned	Date	Ownership
Alexander Y. Tokman	NDRA	Common Stock	Award	35.9%	26,921	101,926	02 Mar 2026	Direct
Richard Jacroux	NDRA	Common Stock	Award	67.3%	13,461	33,461	02 Mar 2026	Direct
Michael Harsh	NDRA	Common Stock	Award	1120%	60,324	65,710	21 Jan 2026	Direct
Richard Jacroux	NDRA	Common Stock	Award		20,000	20,000	21 Jan 2026	Direct
Lou Basenese	NDRA	Common Stock	Award	1120.2%	60,324	65,709	21 Jan 2026	Direct
Alexander Y. Tokman	NDRA	Common Stock	Award	1500000%	75,000	75,005	21 Jan 2026	Direct
Anthony Digiandomenico	NDRA	Common Stock	Award	79.1%	60,324	136,589	21 Jan 2026	Direct
Anthony Digiandomenico	NDRA	Common Stock	Award	1301.2%	70,822	76,265	10 Oct 2025	Direct
Anthony Digiandomenico	NDRA	Warrants	Award		141,644	141,644	10 Oct 2025	Direct
Lou Basenese	NDRA	Common Stock	Award	538400%	5,384	5,385	11 Jun 2025	Direct
Michael Harsh	NDRA	Common Stock	Award	269200%	5,384	5,386	11 Jun 2025	Direct
Anthony Digiandomenico	NDRA	Common Stock	Award	9125.4%	5,384	5,443	11 Jun 2025	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.